SINGAPORE -- Future sales of COVID-19 vaccines will take place in "an annual vaccination market, a lot like influenza," according to Novavax's executive vice president.
Executive vice president wishes for a 'clear path' into China as demand wanes

Novavax's COVID-19 vaccine shots, which can be stored in a regular refrigerator, had a 90% efficacy in their clinical trial. (Nikkei montage/Novavax/Reuters)
SINGAPORE -- Future sales of COVID-19 vaccines will take place in "an annual vaccination market, a lot like influenza," according to Novavax's executive vice president.